Authors:
Hakura, A
Tsutsui, Y
Sonoda, J
Tsukidate, K
Mikami, T
Sagami, F
Citation: A. Hakura et al., Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta (TM) Mouse treated with benzo[a]pyrene: target organ specificity, MUT RES-F M, 447(2), 2000, pp. 239-247
Authors:
Sato, G
Asakura, S
Hakura, A
Tsutsui-Hiyoshi, Y
Kobayashi, N
Tsukidate, K
Citation: G. Sato et al., Assessment of potential mutagenic activities of a novel benzothiazole MAO-A inhibitor E2011 using Salmonella typhimurium YG1029, MUT RES-GTE, 472(1-2), 2000, pp. 163-169
Authors:
Sugihara, T
Sawada, S
Hakura, A
Hori, Y
Uchida, K
Sagami, F
Citation: T. Sugihara et al., A staining procedure for micronucleus test using new methylene blue and acridine orange: specimens that are supravitally stained with possible long-term storage, MUT RES-GTE, 470(2), 2000, pp. 103-108
Citation: T. Kato et al., Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives, MUT RES-GTE, 465(1-2), 2000, pp. 173-182
Authors:
Yoshioka, N
Inoue, H
Nakanishi, K
Oka, K
Yutsudo, M
Yamashita, A
Hakura, A
Nojima, H
Citation: N. Yoshioka et al., Isolation of transformation suppressor genes by cDNA subtraction: Lumican suppresses transformation induced by v-src and v-K-ras, J VIROLOGY, 74(2), 2000, pp. 1008-1013
Authors:
Hakura, A
Tsutsui, Y
Sonoda, J
Mikami, T
Tsukidate, K
Sagami, F
Kerns, WD
Citation: A. Hakura et al., Multiple organ mutation in the lacZ transgenic mouse (Muta (TM) Mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene, MUT RES-F M, 426(1), 1999, pp. 71-77
Citation: T. Kato et al., Effects of oligofluorine substitution on the mutagenicity of quinoline: a study with twelve fluoroquinoline derivatives, MUT RES-GTE, 439(2), 1999, pp. 149-157
Authors:
Oka, K
Tomonaga, Y
Nakazawa, T
Ge, HY
Bengtsson, U
Stanbridge, EJ
Yoshioka, N
Li, Q
Hakura, A
Yutsudo, M
Citation: K. Oka et al., Malignant transformation of human diploid fibroblasts and suppression of their anchorage independence by introduction of chromosome 13, GENE CHROM, 26(1), 1999, pp. 47-53
Citation: A. Yamashita et al., Suppression of anchorage-independent growth of human cancer cell lines by the drs gene, ONCOGENE, 18(34), 1999, pp. 4777-4787
Authors:
Shimakage, M
Kimura, M
Yanoma, S
Ibe, M
Yokota, S
Tsujino, G
Kozuka, T
Dezawa, T
Tamura, S
Ohshima, A
Yutsudo, M
Hakura, A
Citation: M. Shimakage et al., Expression of latent and replicative-infection genes of Epstein-Barr virusin macrophage, ARCH VIROL, 144(1), 1999, pp. 157-166
Authors:
Nakanishi, K
Yoshioka, N
Oka, K
Hakura, A
Citation: K. Nakanishi et al., Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3 ' untranslated region, INT J CANC, 80(4), 1999, pp. 527-532
Authors:
Li, Q
Yoshioka, N
Yutsudo, M
Inafuku, S
Aozasa, K
Kitamura, Y
Aizawa, S
Nishimune, Y
Hakura, A
Kondoh, G
Citation: Q. Li et al., Human papillomavirus-induced carcinogenesis with p53 deficiency in mouse: Novel lymphomagenesis in HPV16E6E7 transgenic mice mimicking p53 defect, VIROLOGY, 252(1), 1998, pp. 28-33